Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins

Medicine & Life Sciences

• Insulin-Like Growth Factor Binding Proteins 100%
• Tamoxifen 80%
• Endometrial Neoplasms 78%
• Insulin-Like Growth Factor I 76%
• Tyrosine 70%
• Phosphorylation 52%
• Growth 38%
• Somatomedins 33%
• Estradiol 27%
• Raloxifene Hydrochloride 17%
• Estrogen Receptor Modulators 16%
• IGF Type 1 Receptor 16%
• Estrogens 10%
• Breast Neoplasms 8%
• Insulin-Like Growth Factor Binding Protein 3 7%
• Membrane Proteins 5%
• Peptides 4%
• Membranes 3%
• Messenger RNA 3%
• Incidence 3%
• Neoplasms 2%
• Therapeutics 1%